Princeton, New Jersey; July 1, 2010 -- Sandoz today announced the introduction of rivastigmine tartrate capsules, an authorized generic equivalent of the Novartis treatment Exelon® capsules ...

CHICAGO--(BUSINESS WIRE)--Exelon is now accepting applications ... Carbon Reform developed the Carbon Capsule®, a modular device that permanently captures CO₂ from indoor air while filtering ...

Mylan (MYL) announced that its U.K.-based subsidiary has launched Rivastigmine Capsules POM, 1.5 mg, 3 mg, 4.5 mg and 6 mg. This product is the generic version of Novartis' (NVS) Exelon Capsules ...

Exelon is up around 25% since my Strong Buy call in November, and the long-term thesis remains intact. In fact, it's now much clearer. Load-driven transmission investment is accelerating as AI ...

Exelon has about 11 gigawatts of likely data-center demand Utility is in fight over co-located data centers 'We are not against co-locations,' Exelon CEO Calvin Butler Exelon Q3 earnings beat Wall ...